![Hassan Javanbakht](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Hassan Javanbakht
Directeur Technique/Scientifique/R&D chez
MIRUM PHARMACEUTICALS, INC.
Profil
Hassan Javanbakht is currently Chief Scientific Officer at Mirum Pharmaceuticals, Inc. Formerly, Chief Scientific Officer at Bluejay Therapeutics, Inc. Education includes a doctorate from McGill University.
Postes actifs de Hassan Javanbakht
| Sociétés | Poste | Début |
|---|---|---|
| MIRUM PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 01/01/2026 |
Anciens postes connus de Hassan Javanbakht
| Sociétés | Poste | Fin |
|---|---|---|
Bluejay Therapeutics, Inc.
 Bluejay Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics treatments for viral and liver diseases | Directeur Technique/Scientifique/R&D | - |
Formation de Hassan Javanbakht
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
22
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
McGill University
 McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mirum Pharmaceuticals, Inc.
 Mirum Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage therapeutics company developing a novel approach for treating cholestasis liver diseases | Health Technology |
Bluejay Therapeutics, Inc.
Bluejay Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics treatments for viral and liver diseases | Health Technology |
